Personalized cancer vaccines show great potential in cancer immunotherapy by inducing an
effective and durable antitumor response. However, the limitation of neoantigen …

White blood cells (WBCs) are a major component of immunity in response to pathogen
invasion. Neutrophils are the most abundant WBCs in humans, playing a central role in …

Most studies on the immunotherapeutic potential of T cells have focused on CD8 and CD4 T
cells that recognize peptide antigens (Ag) presented by polymorphic major histocompatibility …

The implementation of immune checkpoint inhibitors to the oncology clinic signified a new
era in cancer treatment. After the first indication of melanoma, an increasing list of additional …

Tumor tissues/cells are the best sources of antigens to prepare cancer vaccines. However,
due to the difficulty of solubilization and delivery of water‐insoluble antigens in tumor …

The cell membrane-coated nanoparticle is a biomimetic platform consisting of a
nanoparticulate core coated with membrane derived from a cell, such as a red blood cell …

Immunotherapy, where the patient's own immune system is exploited to eliminate tumor
cells, has become one of the most prominent new cancer treatment options in the last …

Human papillomavirus (HPV), a common sexually transmitted virus infecting mucosal or
cutaneous stratified epithelia, is implicated in the rising of associated cancers worldwide …

In recent years, significant evolutions have been made in applying nanotechnologies for
prophylactic and therapeutic cancer vaccine design. However, the clinical translation of …

Cancer immunotherapy is a rapidly evolving concept that has been given the tag" fifth pillar"
of cancer therapy while radiation therapy, chemotherapy, surgery and targeted therapy …